Detalhe da pesquisa
1.
Intrinsic subtypes in Ethiopian breast cancer patient.
Breast Cancer Res Treat;
196(3): 495-504, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36282363
2.
PIK3CA-mutations in breast cancer.
Breast Cancer Res Treat;
196(3): 483-493, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36279023
3.
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
Int J Mol Sci;
23(15)2022 Aug 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35955851
4.
Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy.
Int J Cancer;
148(8): 1993-2009, 2021 04 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33368291
5.
IGF2BP1 is a targetable SRC/MAPK-dependent driver of invasive growth in ovarian cancer.
RNA Biol;
18(3): 391-403, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32876513
6.
Comparison of six breast cancer classifiers using qPCR.
Bioinformatics;
35(18): 3412-3420, 2019 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30759193
7.
The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.
Nucleic Acids Res;
44(8): 3845-64, 2016 05 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26917013
8.
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Breast Cancer Res;
19(1): 112, 2017 Oct 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29020998
9.
Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients.
Strahlenther Onkol;
190(10): 912-8, 2014 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24715245
10.
The prevalence of estrogen receptor-negative breast cancer in Ethiopia.
BMC Cancer;
14: 895, 2014 Nov 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25433805
11.
GRB2 is a BECN1 interacting protein that regulates autophagy.
Cell Death Dis;
15(1): 14, 2024 01 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38182563
12.
Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer.
Breast Cancer Res Treat;
138(3): 839-50, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23568480
13.
Human Breast Tissue Microbiota Reveals Unique Microbial Signatures that Correlate with Prognostic Features in Adult Ethiopian Women with Breast Cancer.
Cancers (Basel);
15(19)2023 Oct 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37835588
14.
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.
Cancers (Basel);
15(5)2023 Mar 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36900372
15.
Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa.
Cancer Immunol Res;
11(6): 720-731, 2023 06 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37058582
16.
FNTB Promoter Polymorphisms Are Independent Predictors of Survival in Patients with Triple Negative Breast Cancer.
Cancers (Basel);
14(3)2022 Jan 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35158735
17.
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
Diagnostics (Basel);
12(10)2022 Oct 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36292215
18.
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel.
BMC Cancer;
11: 140, 2011 Apr 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21496284
19.
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts.
Oncogene;
40(15): 2651-2666, 2021 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33692466
20.
Adherence to Newly Implemented Tamoxifen Therapy for Breast Cancer Patients in Rural Western Ethiopia.
Breast Care (Basel);
16(5): 484-490, 2021 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34720808